المؤلفون: Phillips CJ, Wisdom AJ, McKinnon RA, Woodman RJ, Gordon DL

المصدر: Infection and Drug Resistance, Vol Volume 11, Pp 2081-2094 (2018)

مصطلحات موضوعية: Drug monitoring, Education, Guideline, Implementation, Intervention, Prescribing, Systematic review, Vancomycin, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

Relation: https://www.dovepress.com/interventions-targeting-the-prescribing-and-monitoring-of-vancomycin-f-peer-reviewed-article-IDR; https://doaj.org/toc/1178-6973

URL الوصول: https://doaj.org/article/d7f21dd7ae8248ceb6ce296d64f6ff41

المؤلفون: Wisdom AJ; Harvard Radiation Oncology Program, Boston, Massachusetts., Barker CA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Chang JY; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Demaria S; Department of Radiation Oncology, Weill Cornell Medicine, New York, New York., Formenti S; Department of Radiation Oncology, Weill Cornell Medicine, New York, New York., Grassberger C; Department of Radiation Oncology, University of Washington, Fred Hutch Cancer Center, Seattle, Washington., Gregucci F; Department of Radiation Oncology, Weill Cornell Medicine, New York, New York., Hoppe BS; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida., Kirsch DG; Department of Radiation Oncology, University of Toronto, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Marciscano AE; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Mayadev J; Department of Radiation Oncology, UC San Diego School of Medicine, San Diego, California., Mouw KW; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts., Palta M; Department of Radiation Oncology, Duke Cancer Center, Durham, North Carolina., Wu CC; Department of Radiation Oncology, Columbia University Irving Medical Center, New York, New York., Jabbour SK; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. Electronic address: jabbousk@cinj.rutgers.edu., Schoenfeld JD; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: Jonathan_Schoenfeld@dfci.harvard.edu.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Apr 01; Vol. 118 (5), pp. 1404-1421. Date of Electronic Publication: 2024 Jan 05.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/radiotherapy , Neoplasms*/drug therapy, Humans ; Immunotherapy ; Combined Modality Therapy

المؤلفون: Su C; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Kent CL; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Pierpoint M; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Floyd W; MD Anderson Cancer Center, Houston, TX, USA., Luo L; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Wiliams NT; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Ma Y; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Peng B; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Lazarides AL; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Subramanian A; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Himes JE; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Perez VM; Tempus AI, Inc., Durham, NC, USA., Hernansaiz-Ballesteros RD; Tempus AI, Inc., Durham, NC, USA., Roche KE; Tempus AI, Inc., Durham, NC, USA.; QuantBio, LLC., Durham, NC, USA., Modliszewski JL; QuantBio, LLC., Durham, NC, USA., Selitsky SR; Tempus AI, Inc., Durham, NC, USA.; QuantBio, LLC., Durham, NC, USA., Mari Shinohara; Department of Immunology, Duke University, Durham, NC, USA., Wisdom AJ; Department of Radiation Oncology, Harvard University, Cambridge, MA, USA., Moding EJ; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Mowery YM; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.; MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, PA, USA., Kirsch DG; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA.; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2024 Jan 04. Date of Electronic Publication: 2024 Jan 04.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

المؤلفون: Pierpoint M; Duke of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada., Floyd W; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wisdom AJ; Harvard Radiation Oncology Program, Harvard University, Boston, MA, 02115, USA., Luo L; Duke Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA., Ma Y; Duke Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA., Waitkus MS; Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Department of Neurosurgery, Duke University School of Medicine, Durham, NC 27710, USA.; The Preston Robert Tisch Brain Tumor Center at Duke, Durham, NC 27710, USA., Kirsch DG; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON M5G 2M9, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 2M9, Canada.

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2023 Nov 06. Date of Electronic Publication: 2023 Nov 06.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

المؤلفون: Carpenter DJ; Department of Radiation Oncology, Duke Cancer Institute, Durham, North Carolina, USA., Patel P; Department of Radiation Oncology, Duke Cancer Institute, Durham, North Carolina, USA., Niedzwiecki D; Department of Biostatistics & Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.; Duke Cancer Institute Biostatistics, Duke University Medical Center, Durham, North Carolina, USA., Dillon M; Department of Biostatistics & Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.; Duke Cancer Institute Biostatistics, Duke University Medical Center, Durham, North Carolina, USA., Diaz AK; Department of Radiation Oncology, Duke Cancer Institute, Durham, North Carolina, USA., Kumar A; Department of Radiation Oncology, Duke Cancer Institute, Durham, North Carolina, USA., Mowery YM; Department of Radiation Oncology, Duke Cancer Institute, Durham, North Carolina, USA.; Department of Head and Neck Surgery and Communication Sciences, Duke University Medical Center, Durham, North Carolina, USA., Crowell KA; Department of Biostatistics & Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.; Duke Cancer Institute Biostatistics, Duke University Medical Center, Durham, North Carolina, USA., D'Anna R; Department of Biostatistics & Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA., Wu Q; Department of Radiation Oncology, Duke Cancer Institute, Durham, North Carolina, USA., Rodrigues A; Department of Radiation Oncology, Duke Cancer Institute, Durham, North Carolina, USA., Wisdom AJ; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Dorth JA; Department of Radiation Oncology, Case Western Reserve University, Cleveland, Ohio, USA., Patel PR; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA., Shortell CK; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., Brizel DM; Department of Radiation Oncology, Duke Cancer Institute, Durham, North Carolina, USA.; Department of Head and Neck Surgery and Communication Sciences, Duke University Medical Center, Durham, North Carolina, USA.; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.

المصدر: Cancer [Cancer] 2023 Oct 28. Date of Electronic Publication: 2023 Oct 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

المؤلفون: Wisdom AJ; Harvard Radiation Oncology Program, Boston, MA, USA., Dyer MA; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Horick NK; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Yeap BY; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Miller KK; Harvard Medical School, Boston, MA, USA.; Division of Endocrinology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Swearingen B; Harvard Medical School, Boston, MA, USA.; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA., Loeffler JS; Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, Massachusetts General Hospital, 30 Fruit Street, 02114, Boston, MA, USA., Shih HA; Harvard Medical School, Boston, MA, USA. hshih@mgh.harvard.edu.; Department of Radiation Oncology, Massachusetts General Hospital, 30 Fruit Street, 02114, Boston, MA, USA. hshih@mgh.harvard.edu.

المصدر: Pituitary [Pituitary] 2023 Aug; Vol. 26 (4), pp. 510-520. Date of Electronic Publication: 2023 Jul 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Publishers Country of Publication: United States NLM ID: 9814578 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7403 (Electronic) Linking ISSN: 1386341X NLM ISO Abbreviation: Pituitary Subsets: MEDLINE

مواضيع طبية MeSH: Pituitary Neoplasms*/radiotherapy , Pituitary Neoplasms*/surgery , Hypopituitarism*/diagnosis, Humans ; Middle Aged ; Quality of Life ; Surveys and Questionnaires ; Fatigue ; Treatment Outcome

المؤلفون: Floyd W; Department of Pharmacology and Cancer Biology, and., Pierpoint M; Department of Pharmacology and Cancer Biology, and., Su C; Department of Pharmacology and Cancer Biology, and., Patel R; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., Luo L; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., Deland K; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., Wisdom AJ; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Zhu D; Department of Pharmacology and Cancer Biology, and., Ma Y; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., DeWitt SB; Department of Orthopaedics and., Williams NT; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA., Lazarides AL; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Somarelli JA; Department of Sarcoma, Moffitt Cancer Center, Tampa, Florida, USA.; Duke Cancer Institute, Durham, North Carolina, USA., Corcoran DL; Center for Genomic and Computational Biology, Duke University, Durham, North Carolina, USA., Eward WC; Department of Orthopaedics and., Cardona DM; Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA., Kirsch DG; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Radiation Oncology and.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

المصدر: The Journal of clinical investigation [J Clin Invest] 2023 Jul 03; Vol. 133 (13). Date of Electronic Publication: 2023 Jul 03.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: Sarcoma*/genetics , Sarcoma*/radiotherapy , Herpesviridae*, Animals ; Mice ; Humans ; Signal Transduction ; X-linked Nuclear Protein/genetics ; Nucleotidyltransferases/genetics ; Nucleotidyltransferases/metabolism ; Immunity, Innate

المؤلفون: Himes JE; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27708, USA., Wisdom AJ; Harvard Radiation Oncology Program, Harvard University, Boston, MA, 02115., Wang L; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27708, USA., Shepard SJ; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27708, USA., Daniel AR; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27708, USA., Williams N; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27708, USA., Luo L; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27708, USA., Ma Y; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27708, USA., Mowery YM; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27710, USA.; Duke Cancer Institute, Durham, NC, 27710, USA.; Department of Head and Neck Surgery & Communication Sciences, Duke University Medical Center, Durham, NC, 27710, USA., Kirsch DG; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27708, USA.; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27710, USA.; Duke Cancer Institute, Durham, NC, 27710, USA.

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2023 Apr 06. Date of Electronic Publication: 2023 Apr 06.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

المؤلفون: Borchmann S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany sven.borchmann@uk-koeln.de roland.ullrich@uk-koeln.de.; Center for Molecular Medicine, University of Cologne, Cologne, Germany., Selenz C; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; Center for Molecular Medicine, University of Cologne, Cologne, Germany., Lohmann M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Ludwig H; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; Center for Molecular Medicine, University of Cologne, Cologne, Germany., Gassa A; Department of Cardiothoracic Surgery, University of Cologne, Cologne, Germany., Brägelmann J; Mildred Scheel School of Oncology, University Hospital Cologne, Medical Faculty, Cologne, Germany., Lohneis P; Institute of Pathology, University of Cologne, Cologne, Germany., Meder L; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; Center for Molecular Medicine, University of Cologne, Cologne, Germany., Mattlener J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Breid S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; Center for Molecular Medicine, University of Cologne, Cologne, Germany., Nill M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; Center for Molecular Medicine, University of Cologne, Cologne, Germany., Fassunke J; Institute of Pathology, University of Cologne, Cologne, Germany., Wisdom AJ; Department of Radiation Oncology and Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA., Compes A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.; Center for Molecular Medicine, University of Cologne, Cologne, Germany., Gathof B; Institute of Transfusion Medicine, University of Cologne, Cologne, Germany., Alakus H; Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany., Kirsch D; Department of Radiation Oncology and Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA., Hekmat K; Department of Cardiothoracic Surgery, University of Cologne, Cologne, Germany., Büttner R; Institute of Pathology, University of Cologne, Cologne, Germany., Reinhardt HC; Department of Hematology and Stem Cell Transplantation, University Hospital Essen,University Duisburg-Essen, German Cancer Consortium (DKTK partner site Essen), Essen, Germany., Hallek M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Ullrich RT; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany sven.borchmann@uk-koeln.de roland.ullrich@uk-koeln.de.; Center for Molecular Medicine, University of Cologne, Cologne, Germany.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Oct; Vol. 10 (10).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/therapy , Toll-Like Receptor 3*, Animals ; Combined Modality Therapy ; Epitopes ; Immunotherapy/methods ; Mice

المؤلفون: Wisdom AJ; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27708, USA., Mowery YM; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27708, USA. yvonne.mowery@duke.edu.; Duke Cancer Institute, Durham, NC, 27708, USA. yvonne.mowery@duke.edu., Hong CS; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27708, USA., Himes JE; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27708, USA., Nabet BY; Stanford Cancer Institute, Stanford University, Stanford, CA, 94305, USA.; Department of Oncology Biomarker Development, Genentech, South San Francisco, CA, 94080, USA., Qin X; Duke Cancer Institute, Durham, NC, 27708, USA., Zhang D; Duke Cancer Institute, Durham, NC, 27708, USA., Chen L; Merck & Co., Inc, Kenilworth, NJ, 07033, USA., Fradin H; Duke Center for Genomic and Computational Biology, Durham, NC, 27708, USA., Patel R; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27708, USA., Bassil AM; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27708, USA., Muise ES; Merck & Co., Inc, Kenilworth, NJ, 07033, USA., King DA; Stanford Cancer Institute, Stanford University, Stanford, CA, 94305, USA.; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, 94305, USA., Xu ES; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27708, USA., Carpenter DJ; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27708, USA., Kent CL; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27708, USA., Smythe KS; Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA., Williams NT; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27708, USA., Luo L; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27708, USA., Ma Y; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27708, USA., Alizadeh AA; Stanford Cancer Institute, Stanford University, Stanford, CA, 94305, USA.; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, 94305, USA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, 94305, USA., Owzar K; Duke Cancer Institute, Durham, NC, 27708, USA.; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, 27710, USA., Diehn M; Stanford Cancer Institute, Stanford University, Stanford, CA, 94305, USA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, 94305, USA.; Department of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA., Bradley T; Department of Medicine, Duke University Medical Center, Durham, NC, 27710, USA.; Center for Pediatric Genomic Medicine, Children's Mercy Kansas City, Kansas City, MO, 64108, USA., Kirsch DG; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27708, USA. david.kirsch@duke.edu.; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27708, USA. david.kirsch@duke.edu.; Duke Cancer Institute, Durham, NC, 27708, USA. david.kirsch@duke.edu.

المصدر: Nature communications [Nat Commun] 2020 Dec 17; Vol. 11 (1), pp. 6410. Date of Electronic Publication: 2020 Dec 17.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Sarcoma/*therapy , Single-Cell Analysis/*methods , Tumor Microenvironment/*immunology, Animals ; Antineoplastic Agents, Immunological/pharmacology ; Bone Marrow Transplantation ; CD8-Positive T-Lymphocytes/immunology ; DNA-Binding Proteins/genetics ; Drug Resistance, Neoplasm/immunology ; Gene Expression Regulation, Neoplastic ; Humans ; Immunotherapy ; Mice, Inbred Strains ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Sarcoma/genetics ; Sarcoma/immunology ; Tumor Escape ; Tumor Microenvironment/genetics ; Exome Sequencing